Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer

被引：0
|
作者：
Burris, HA
Hainsworth, JD
Erland, JB
Morrissey, LH
Kalman, LA
Hon, JK
Scullin, DC
Smith, SW
Greco, FA
机构：
[1] Sarah Cannon Canc Ctr, Nashville, TN 37203 USA
[2] Tennessee Oncol, Nashville, TN USA
[3] Oncol Hematol Grp S Florida, Miami, FL USA
[4] Ctr Comprehens Canc, Huntsville, AL USA
来源：
SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9 / 13
页数：5
相关论文
共 50 条
  • [31] A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Kenzo Soejima
    Katsuhiko Naoki
    Kota Ishioka
    Morio Nakamura
    Michie Nakatani
    Ichiro Kawada
    Hideo Watanabe
    Ichiro Nakachi
    Hiroyuki Yasuda
    Ryosuke Satomi
    Sohei Nakayama
    Satoshi Yoda
    Sinnosuke Ikemura
    Hideki Terai
    Takashi Sato
    Keiko Ohgino
    Daisuke Arai
    Tetsuo Tani
    Aoi Kuroda
    Makoto Nishino
    Tomoko Betsuyaku
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 513 - 519
  • [32] Biweekly carboplatin and gemcitabine for untreated advanced non-small cell lung cancer (NSCLC). A multicenter phase II trial
    Domine, M
    Gomez, RG
    Firvida, J
    Delgado, J
    Estevez, L
    Docampo, LI
    Leon, A
    Pachon, V
    Casado, V
    Lobo, F
    LUNG CANCER, 2005, 49 : S242 - S242
  • [33] A phase I/II study of bexarotene with carboplatin and weekly paclitaxel for the treatment of patients with advanced non-small cell lung cancer
    Dragnev, Konstantin H.
    Whyman, Jeremy D.
    Hahn, Cynthia K.
    Kebbekus, Peter E.
    Kokko, Sarah F.
    Bhatt, Sunil M.
    Rigas, James R.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (09) : 5531 - 5537
  • [34] Gemcitabine/carboplatin in advanced non-small cell lung cancer
    Zatloukal, P
    Petruzelka, L
    LUNG CANCER, 2002, 38 : S33 - S36
  • [35] A PHASE I/II STUDY OF BEXAROTENE WITH WEEKLY PACLITAXEL AND CARBOPLATIN FOR THE TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Whyman, Jeremy D.
    Kebbekus, Peter E.
    Fink, Sarah K.
    Rigas, James R.
    Dragnev, Konstantin H.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S883 - S883
  • [36] A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)
    Giorgio, CG
    Pappalardo, A
    Russo, A
    Giuffrida, D
    Santini, D
    Petralia, G
    Castorina, S
    Nunzio, R
    Failla, G
    Bordonaro, R
    LUNG CANCER, 2006, 51 (03) : 357 - 362
  • [37] Phase II trial of gemcitabine-carboplatin-paclitaxel (GCP) as neo-adjuvant chemotherapy for operable non-small cell lung cancer (NSCLC)
    Abratt, R
    Lee, J
    Han, J
    Tsai, C
    Boyer, M
    Mok, T
    Kim, S
    Lee, J
    Brnabic, A
    Lehnert, M
    LUNG CANCER, 2005, 49 : S92 - S92
  • [38] Phase II trial of gemcitabine-carboplatin-paclitaxel (GCP) as neo-adjuvant chemotherapy for operable non-small cell lung cancer (NSCLC).
    Abratt, RP
    Lee, JS
    Han, JY
    Tsai, CM
    Boyer, M
    Mok, T
    Kim, SW
    Lee, JS
    Brnabic, AJM
    Lehnert, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 685S - 685S
  • [39] Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study
    Piantedosi, F. V.
    Caputo, F.
    Mazzarella, G.
    Gilli, M.
    Pontillo, A.
    D'Agostino, D.
    Campbell, S.
    Marsico, S. A.
    Bianco, A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (05) : 803 - 807
  • [40] Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study
    F. V. Piantedosi
    F. Caputo
    G. Mazzarella
    M. Gilli
    A. Pontillo
    D. D’Agostino
    S. Campbell
    S. A. Marsico
    A. Bianco
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 803 - 807
12345